Nasonex (Mometasone Furoate)

Mometasone furoate, the active ingredient in Nasonex, is a corticosteroid presented as a nasal spray for nasal use. It treats allergic rhinitis and nasal polyps in adults and children as directed by a healthcare professional.

GNH USA supplies Nasonex as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nasonex (mometasone furoate) is used to manage inflammatory conditions of the nasal passages.

Allergic rhinitis: reduces nasal congestion, itching and sneezing. Nasal polyps: decreases polyp size and improves airflow. Seasonal allergic rhinitis: provides symptom relief during pollen exposure.

Nasonex may cause a range of adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nasal irritation or burning - Headache - Epistaxis (nosebleed) - Throat irritation - Cough - Altered taste perception

Serious or Rare Side Effects: - Nasal septal perforation - Severe or prolonged epistaxis - Adrenal suppression with long‑term use - Vision changes such as cataract formation - Fungal infection of the nasal cavity - Anaphylactic or severe allergic reactions

Before using Nasonex, consider the following safety measures.

Pregnancy: consult a healthcare provider as safety has not been fully established. Pediatric use: follow prescriber guidance; safety data are limited for very young children. Concurrent nasal surgery: postpone treatment until postoperative healing is complete. Systemic corticosteroid therapy: monitor for additive systemic effects. Immunocompromised patients: use with caution due to potential infection risk. Store at room temperature: keep in the original container, protect from moisture and heat.

Nasonex can interact with other medicines; awareness helps minimize risk.

Major Interactions (Avoid): - Systemic corticosteroids: may increase overall glucocorticoid exposure. - Strong CYP3A4 inhibitors (e.g., ketoconazole): can raise local drug levels. - Live vaccines: may reduce vaccine efficacy.

Moderate Interactions (Monitor Closely): - Antifungal azoles: monitor for increased nasal irritation. - Ritonavir: may modestly raise mometasone exposure. - Nasal decongestants: may exacerbate nasal dryness.